Heart failure patients living longer, but long-term survival still low

May 16, 2013

People hospitalized for acute heart failure are likely to survive longer compared to the prior decade, according to a new study in the Journal of the American Heart Association and presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013.

But overall, long-term survival rates remain low, researchers said.

Unlike , in which patients are able to live at home, involves a severe deterioration in health. Fluid backs up in the lungs, breathing becomes difficult and the heart is unable to supply the body's necessary oxygen.

"Heart failure is a with a worse life expectancy than many types of cancer," said Samuel W. Joffe, M.D., lead author of the study and a cardiac fellow at the University of Massachusetts Memorial Medical Center, in Worcester. People hospitalized with heart failure are "very sick and their life expectancy is quite limited."

Comparing 9,748 patients admitted to 11 central Massachusetts medical centers with acute decompensated heart failure in 1995 to those in 2004, researchers found good and bad news:

  • The proportion of people who died while hospitalized in 2004 decreased 21 percent compared to 1995.
  • The proportion who died within 30 days of discharge in 2004 decreased 18 percent compared to 1995.
  • Long-term survival, 5 years or more, improved by 45% in 2004 compared to 1995.
  • Patients admitted to hospitals in 2004 with acute decompensated heart failure were older and sicker than those admitted in 1995.
  • Patients in 2004 were more likely to have other such as anemia, high blood pressure and .

"While survival for patients in this study improved significantly, their prognosis was still poor, as only about one in three of these patients hospitalized with heart failure survived five years or more," Joffe said.

Treatment guidelines for heart failure, released jointly in 1995 by the and American College of Cardiology, may have played a role in the short-term improvements, Joffe said.

Patients hospitalized in 2004 were more likely to be treated with aspirin, beta blockers and lipid-lowering agents or statins. They were less likely to be treated with calcium channel blockers and digoxin.

It's not clear if changes in medications directly caused the increase in survival, Joffe said, noting that better pacemakers, defibrillators, overall medical care, or other factors also may have played a role.

Heart attack remains the leading cause of heart failure. Eating fresh fruits, vegetables, whole grains and lean protein sources, as well as exercising regularly, avoiding smoking and maintaining healthy cholesterol and blood pressure levels can help prevent heart attack and thus .

Explore further: Getting fit in middle age can reduce heart failure risk

Related Stories

Getting fit in middle age can reduce heart failure risk

May 15, 2013
Middle aged and out of shape? It's not too late to get fit—and reduce your risk for heart failure, according to research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions ...

Drug may improve outcomes after heart attack

March 12, 2013
The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's ...

Young women often less healthy than young men before heart attacks

May 15, 2013
Young women tend to be less healthy and have a poorer quality of life than similar-aged men before suffering a heart attack, according to research presented at the American Heart Association's Quality of Care and Outcomes ...

Digoxin reduces hospital admissions in older patients with chronic heart failure

March 12, 2013
Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented today ...

Ultrafiltration may not be best approach for heart failure patients, research finds

November 7, 2012
Ultrafiltration was no more effective in removing excess fluid from the heart than using standard treatment including diuretics to reduce congestion in heart failure patients, according to late-breaking clinical trial research ...

Hospital survival differs among Hispanic and non-Hispanic heart failure patients

March 13, 2012
The odds of surviving their hospital stay for heart failure differ between Hispanic and non-Hispanic white patients according to their level of heart function, even when they received equal care in hospitals participating ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.